UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 801

Sortiert nach

Exploring the wet granulation growth regime map – validating the boundary between nucleation and induction

Chemical engineering research & design, 2020-04, Vol.156, p.469-477

2020

Link zum Volltext

Verfügbarkeit prüfen

Late Accretion on the Earliest Planetesimals Revealed by the Highly Siderophile Elements

Science (American Association for the Advancement of Science), 2012-04, Vol.336 (6077), p.72-75

2012

Link zum Volltext

Verfügbarkeit prüfen

The development of a growth regime map for a novel reverse-phase wet granulation process

International journal of pharmaceutics, 2016-10, Vol.512 (1), p.224-233

2016

Link zum Volltext

Verfügbarkeit prüfen

Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9514-9514

2020

Link zum Volltext

Verfügbarkeit prüfen

An assessment of powder pycnometry as a means of determining granule porosity

Pharmaceutical development and technology, 2015-05, Vol.20 (3), p.257-265

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3004-3004

2017

Link zum Volltext

Verfügbarkeit prüfen

CheckMate 012: Safety and efficacy of first-line (1L) nivolumab (nivo; N) and ipilimumab (ipi; I) in advanced (adv) NSCLC

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3001-3001

2016

Link zum Volltext

Verfügbarkeit prüfen

Tuning interfacial interactions for bottom‐up assembly of surface‐anchored metal‐organic frameworks to tailor film morphology and pattern surface features

Aggregate (Hoboken), 2022-08, Vol.3 (4), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

First-in-human evaluation of CO-1686, an irreversible, highly selective tyrosine kinase inhibitor of mutations of EGFR (activating and T790M)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8010-8010

2014

Link zum Volltext

Verfügbarkeit prüfen

Power and Corruption in the Early Modern Portuguese World by Erik Lars Myrup (review)

Hispania, 2017, Vol.100 (1), p.144-145

Wade, Jonathan

2017

Link zum Volltext

Verfügbarkeit prüfen

First-in-human evaluation of CO-1686, an irreversible, selective, and potent tyrosine kinase inhibitor of EGFR T790M

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2524-2524

2013

Link zum Volltext

Verfügbarkeit prüfen

Formulation in a drop - Templated granulation and compaction analysis

Powder technology, 2024-04, Vol.438, Article 119611

2024

Link zum Volltext

Verfügbarkeit prüfen

El secreto a voces

Bulletin of the Comediantes, 2014-07, Vol.66 (2), p.260-261

Wade, Jonathan

2014

Link zum Volltext
ProQuest

Cervantes and Modernity

Arizona Journal of Hispanic Cultural Studies, 2007-01, Vol.11 (1), p.229-230

Wade, Jonathan William

2007

Link zum Volltext

Verfügbarkeit prüfen

Don Quixote in the Archives: Madness and Literature in Early Modern Spain by Dale Shuger (review)

Hispania, 2013-12, Vol.96 (4), p.798-799

Wade, Jonathan

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 study of an off-the shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2616-2616

2021

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA

Journal of clinical oncology, 2020-06, Vol.38 (18_suppl), p.LBA5-LBA5

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of ADXS-503 alone and in combination with pembrolizumab in subjects with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21682-e21682

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib/II study of niraparib plus temozolomide plus atezolizumab versus atezolizumab as maintenance therapy in extensive-stage small cell lung cancer (TRIO-US L-06)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS9084-TPS9084

2020

Link zum Volltext

Verfügbarkeit prüfen

Neratinib efficacy in a subgroup of patients with EGFR exon 18 - mutant non-small cell lung cancer (NSCLC) and central nervous system (CNS) involvement: Findings from the SUMMIT basket trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9068-9068

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of chemotherapy plus immune checkpoint inhibitors in oncogenic driven non-small cell lung cancer: A University of California Lung Cancer Consortium retrospective study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9059-9059

2021

Link zum Volltext

Verfügbarkeit prüfen

EGFR-mutation detection in VTX-1-enriched CTCs, ctDNA, and comparison to tumor in patients with non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20525-e20525

2017

Link zum Volltext

Verfügbarkeit prüfen

c-Met expression and response to telisotuzumab vedotin (teliso-v) in patients with non-small cell lung cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9023-9023

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of MEDI0562 in combination with durvalumab or tremelimumab in patients with advanced solid tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3003-3003

2020

Link zum Volltext

Verfügbarkeit prüfen

Personajes que se le olvidaron a Montalvo: La caracterización femenina en Capítulos que se le olvidaron a Cervantes

Hispania, 2011-12, Vol.94 (4), p.637-647

Wade, Jonathan

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 801

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(668)
Mit Volltextzugriff
(657)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(453)
Life Sciences & Biomedicine
(371)
Humans
(290)
Male
(147)
Female
(144)
Adult
(95)
Middle Aged
(94)
Aged
(79)
Computer Science
(61)
General & Internal Medicine
(60)
Biological And Medical Sciences
(58)
Animals
(50)
Patients
(48)
Neurosciences & Neurology
(45)
Oncology
(43)
Treatment Outcome
(43)
Physical Sciences
(41)
Medical Sciences
(40)
Science & Technology - Other Topics
(40)
Medicine, General & Internal
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Exploring the wet granulation growth regime map – validating the boundary between nucleation and induction

Late Accretion on the Earliest Planetesimals Revealed by the Highly Siderophile Elements

The development of a growth regime map for a novel reverse-phase wet granulation process

Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients

An assessment of powder pycnometry as a means of determining granule porosity

Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients

CheckMate 012: Safety and efficacy of first-line (1L) nivolumab (nivo; N) and ipilimumab (ipi; I) in advanced (adv) NSCLC

Tuning interfacial interactions for bottom‐up assembly of surface‐anchored metal‐organic frameworks to tailor film morphology and pattern surface features

First-in-human evaluation of CO-1686, an irreversible, highly selective tyrosine kinase inhibitor of mutations of EGFR (activating and T790M)

Power and Corruption in the Early Modern Portuguese World by Erik Lars Myrup (review)

First-in-human evaluation of CO-1686, an irreversible, selective, and potent tyrosine kinase inhibitor of EGFR T790M

Formulation in a drop - Templated granulation and compaction analysis

El secreto a voces

Cervantes and Modernity

Don Quixote in the Archives: Madness and Literature in Early Modern Spain by Dale Shuger (review)

A phase 1 study of an off-the shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy

Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA

A phase I study of ADXS-503 alone and in combination with pembrolizumab in subjects with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC)

A phase Ib/II study of niraparib plus temozolomide plus atezolizumab versus atezolizumab as maintenance therapy in extensive-stage small cell lung cancer (TRIO-US L-06)

Neratinib efficacy in a subgroup of patients with EGFR exon 18 - mutant non-small cell lung cancer (NSCLC) and central nervous system (CNS) involvement: Findings from the SUMMIT basket trial

The role of chemotherapy plus immune checkpoint inhibitors in oncogenic driven non-small cell lung cancer: A University of California Lung Cancer Consortium retrospective study

EGFR-mutation detection in VTX-1-enriched CTCs, ctDNA, and comparison to tumor in patients with non-small cell lung cancer (NSCLC)

c-Met expression and response to telisotuzumab vedotin (teliso-v) in patients with non-small cell lung cancer

Safety and tolerability of MEDI0562 in combination with durvalumab or tremelimumab in patients with advanced solid tumors

Personajes que se le olvidaron a Montalvo: La caracterización femenina en Capítulos que se le olvidaron a Cervantes

Suchergebnisse filtern